Condensed Consolidated Statement of Equity Statement - USD ($) shares in Millions, $ in Millions	Total	Preferred stock	Common stock	Additional paid-in capital	Accumulated Other Comprehensive Income	Retained earnings	Treasury stock	Noncontrolling interest	Parent	2019 Share Repurchase Program	2019 Share Repurchase Program Common stock	2019 Share Repurchase Program Additional paid-in capital	2019 Share Repurchase Program Retained earnings	2019 Share Repurchase Program Treasury stock	2018 Share Repurchase Program	2018 Share Repurchase Program Common stock	2018 Share Repurchase Program Additional paid-in capital	2018 Share Repurchase Program Retained earnings	2018 Share Repurchase Program Treasury stock	2016 Share Repurchase Program	2016 Share Repurchase Program Common stock	2016 Share Repurchase Program Additional paid-in capital	2016 Share Repurchase Program Retained earnings	2016 Share Repurchase Program Treasury stock	Accounting Standards Update 2016-01 Accumulated Other Comprehensive Income	Accounting Standards Update 2016-16 Retained earnings
Beginning balance at Dec. 31, 2017	$ 12,598.1	$ 0.0	$ 0.1	$ 97.8	$ (318.4)	$ 15,810.4	$ (2,977.1)
Beginning balance, shares at Dec. 31, 2017		0.0	(211.5)				(23.8)
Beginning balance at Dec. 31, 2017	12,612.8
Beginning balance at Dec. 31, 2017								$ (14.7)
Net income attributable to Biogen Inc.	2,039.5					2,039.5
Net income (loss) attributable to noncontrolling interest, net of tax	46.7							46.7
Net income	2,086.2
Other comprehensive income (loss), net of tax	55.3				55.3
Other comprehensive income (loss), net of tax	55.0							(0.3)
Noncontrolling interest, increase (decrease) other	11.1							11.1	$ 0.0
Noncontrolling interest, decrease from distributions to noncontrolling interest holders	(50.0)							50.0	0.0
Repurchase of common stock, at cost																				$ (3,000.0)				$ (3,000.0)
Repurchase of common stock, at cost, shares																				(10.5)				(10.5)
Retirement of common stock pursuant to Share Repurchase Progams, at cost																				$ 0.0	$ 0.0	$ (171.2)	$ (2,828.8)	$ (3,000.0)
Retirement of common stock pursuant to Share Repurchase Programs, at cost, shares																					(10.5)			(10.5)
Issuance of common stock under stock option and stock purchase plans	24.6		$ 0.0	24.6
Issuance of common stock under stock option and stock purchase plans, shares			0.1
Issuance of common stock under award plan			0.3
Issuance of common stock under stock award plan	(38.8)		$ 0.0	(38.8)
Compensation related to share-based payments	87.6			87.6
Adoption of new accounting guidance	479.9																								$ 1.5	$ 478.4
Ending balance at Jun. 30, 2018	12,253.7	$ 0.0	$ 0.1	0.0	(261.6)	15,499.5	$ (2,977.1)
Ending balance at Jun. 30, 2018	12,260.9
Ending balance at Jun. 30, 2018								(7.2)
Ending balance, shares at Jun. 30, 2018		0.0	(201.4)				(23.8)
Beginning balance at Mar. 31, 2018	14,037.5	$ 0.0	$ 0.1	0.0	(303.9)	17,334.6	$ (2,977.1)
Beginning balance, shares at Mar. 31, 2018		0.0	(211.0)				(23.8)
Beginning balance at Mar. 31, 2018	14,053.7
Beginning balance at Mar. 31, 2018								(16.2)
Net income attributable to Biogen Inc.	866.6					866.6
Net income (loss) attributable to noncontrolling interest, net of tax	48.4							48.4
Net income	915.0
Other comprehensive income (loss), net of tax	42.3				42.3
Other comprehensive income (loss), net of tax	41.8							(0.5)
Noncontrolling interest, increase (decrease) other	11.1							11.1	0.0
Noncontrolling interest, decrease from distributions to noncontrolling interest holders	(50.0)							50.0	0.0
Repurchase of common stock, at cost																				$ (2,750.0)				$ (2,750.0)
Repurchase of common stock, at cost, shares																				(9.6)				(9.6)
Retirement of common stock pursuant to Share Repurchase Progams, at cost																				$ 0.0	$ 0.0	$ (48.3)	$ (2,701.7)	$ (2,750.0)
Retirement of common stock pursuant to Share Repurchase Programs, at cost, shares																					(9.6)			(9.6)
Issuance of common stock under stock option and stock purchase plans	8.4		$ 0.0	8.4
Issuance of common stock under stock option and stock purchase plans, shares			0.0
Issuance of common stock under award plan			0.0
Issuance of common stock under stock award plan	(1.5)		$ 0.0	(1.5)
Compensation related to share-based payments	41.4			41.4
Ending balance at Jun. 30, 2018	12,253.7	$ 0.0	$ 0.1	0.0	(261.6)	15,499.5	$ (2,977.1)
Ending balance at Jun. 30, 2018	12,260.9
Ending balance at Jun. 30, 2018								(7.2)
Ending balance, shares at Jun. 30, 2018		0.0	(201.4)				(23.8)
Beginning balance at Dec. 31, 2018	13,031.6	$ 0.0	$ 0.1	0.0	(240.4)	16,257.0	$ (2,977.1)
Beginning balance, shares at Dec. 31, 2018		0.0	(221.0)				(23.8)
Beginning balance at Dec. 31, 2018	13,039.6
Beginning balance at Dec. 31, 2018	(8.0)							(8.0)
Net income attributable to Biogen Inc.	2,902.9					2,902.9
Net income (loss) attributable to noncontrolling interest, net of tax	0.0							0.0
Net income	2,902.9
Other comprehensive income (loss), net of tax	(12.5)				(12.5)
Other comprehensive income (loss), net of tax	(12.9)							(0.4)
Noncontrolling interest, increase (decrease) other	4.3							4.3	0.0
Repurchase of common stock, at cost										$ (909.9)				$ (909.9)	$ (2,147.4)				$ (2,147.4)
Repurchase of common stock, at cost, shares										(3.9)				(3.9)	(8.9)				(8.9)
Retirement of common stock pursuant to Share Repurchase Progams, at cost										$ 0.0	$ 0.0	$ (19.7)	$ (890.2)	$ (909.9)	$ 0.0	$ 0.0	$ (110.5)	$ (2,036.9)	$ (2,147.4)
Retirement of common stock pursuant to Share Repurchase Programs, at cost, shares											(3.9)			(3.9)		(8.9)			(8.9)
Issuance of common stock under stock option and stock purchase plans	26.2		$ 0.0	26.2
Issuance of common stock under stock option and stock purchase plans, shares			0.1
Issuance of common stock under award plan			0.3
Issuance of common stock under stock award plan	(50.0)		$ 0.0	0.0		(50.0)
Compensation related to share-based payments	104.0			104.0
Ending balance at Jun. 30, 2019	12,948.8	$ 0.0	$ 0.1	0.0	(252.9)	16,182.8	$ (2,977.1)
Ending balance at Jun. 30, 2019	12,952.9
Ending balance at Jun. 30, 2019	(4.1)							(4.1)
Ending balance, shares at Jun. 30, 2019		0.0	(208.6)				(23.8)
Beginning balance at Mar. 31, 2019	13,822.0	$ 0.0	$ 0.1	0.0	(219.8)	17,026.7	$ (2,977.1)
Beginning balance, shares at Mar. 31, 2019		0.0	(219.0)				(23.8)
Beginning balance at Mar. 31, 2019	13,829.9
Beginning balance at Mar. 31, 2019								(7.9)
Net income attributable to Biogen Inc.	1,494.1					1,494.1
Net income (loss) attributable to noncontrolling interest, net of tax	0.0							0.0
Net income	1,494.1
Other comprehensive income (loss), net of tax	(33.1)				(33.1)
Other comprehensive income (loss), net of tax	(33.5)							(0.4)
Noncontrolling interest, increase (decrease) other	4.2							4.2	$ 0.0
Repurchase of common stock, at cost										(909.9)				$ (909.9)	$ (1,491.6)				$ (1,491.6)
Repurchase of common stock, at cost, shares														(3.9)	(6.5)				(6.5)
Retirement of common stock pursuant to Share Repurchase Progams, at cost										$ 0.0	$ 0.0	$ (19.7)	$ (890.2)	$ (909.9)	$ 0.0	$ 0.0	$ (44.9)	$ (1,446.7)	$ (1,491.6)
Retirement of common stock pursuant to Share Repurchase Programs, at cost, shares											(3.9)			(3.9)		(6.5)			(6.5)
Issuance of common stock under stock option and stock purchase plans	9.6		$ 0.0	9.6
Issuance of common stock under stock option and stock purchase plans, shares			0.0
Issuance of common stock under award plan			0.0
Issuance of common stock under stock award plan	(1.1)		$ 0.0	0.0		(1.1)
Compensation related to share-based payments	55.0			55.0
Ending balance at Jun. 30, 2019	12,948.8	$ 0.0	$ 0.1	$ 0.0	$ (252.9)	$ 16,182.8	$ (2,977.1)
Ending balance at Jun. 30, 2019	12,952.9
Ending balance at Jun. 30, 2019	$ (4.1)							$ (4.1)
Ending balance, shares at Jun. 30, 2019		0.0	(208.6)				(23.8)